National Healthcare's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is National Healthcare's ROA in the third quarter of 2026?
National Healthcare Corp achieved a return on average assets (ROA) of 5.77 % in its third quarter of 2026, which is below National Healthcare's average return on assets, which stands at 7.02%.

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 101 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 756, from total ROA ranking in the second quarter of 2026 at 907.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	72.08 %	39.97 %	1.41 %	8 %	5.58 %
Y / Y Net Income Change	-66.75 %	68.11 %	11.81 %	317.88 %	-3.96 %
Net Income (TTM) in million	115	143	126	123	103
Return On Assets (TTM)	5.77 %	8.32 %	8.09 %	7.88 %	6.77 %
NHC's Total Ranking	# 756	# 907	# 931	# 925	# 875
Total Assets (TTM) in million	2,705	2,162	1,566	1,565	1,572
Seq. Total Assets Change	25.11 %	38.07 %	0.06 %	-0.44 %	1.76 %
Seq. Net Income Change	-66.36 %	12.28 %	43.3 %	-38.56 %	70.07 %

NHC's 5 Years Annual ROA >> Back to NHC Management Effectiveness >> Compare NHC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 7
Sector	# 102
Overall	# 655

Return On Assets Statistics
High	Average	Low
36.79 %	7.02 %	1.23 %
(Dec 31 2015)		(Mar 31 2023)

Financial Statements
National Healthcare's Assets	$ 2,705 million	NHC's Balance sheet
National Healthcare's Income	$ 14 million	Quarterly NHC's Income Statement
NHC's Income by Division		See NHC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	8.03 %	18.95 %	5.21 %	-7.36 %	6.45 %
Total Assets in million	1,565	1,449	1,218	1,158	1,249
Y / Y Net Income Change	20.1 %	56.36 %	226.82 %	-85.64 %	231.24 %
Net Income in million	123	102	65	20	139
Annual Return On Assets	7.83 %	7.05 %	5.36 %	1.73 %	11.13 %

NHC's 5 Years Annual ROA >> Back to NHC Management Effectiveness >> Compare NHC ROA to its Competitors

Comment on NHC's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 7.83 % compared to prior year, due to annual net income growth of 20.1 % to $122.61 million, while value of National Healthcare's overall assets grew just by 8.03 % to $1,565.15 million, compared to $1,565.15 a year before.

More Return On Assets Ratios
NHC's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NHC's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NHC's Competitors
Subscribers only: Roa for National Healthcare's Suppliers
Subscribers only: Return On Assets for NHC's Customers

You may also want to know
NHC's Roi	NHC's Inventory Turnover Ratio	NHC's Growth Rates	NHC's Dividend Comparisons
	NHC's Profitability Ratios	NHC's Asset Turnover Ratio	NHC's Dividend Growth
NHC's Roe	NHC's Valuation Ratios	NHC's Financial Strength Ratios	NHC's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Bristol myers Squibb Company	10.47 %
3m Company	9.60 %
Bioventus Inc	9.47 %
Medinotec Inc	8.67 %
Tactile Systems Technology Inc	8.53 %
Penumbra Inc	8.13 %
Johnson and Johnson	8.06 %
Pacific Health Care Organization Inc	7.83 %
Boston Scientific Corporation	7.82 %
Stryker Corp	7.66 %
Abbvie Inc	7.48 %
Ensign Group Inc	7.00 %
Pediatrix Medical Group Inc	6.99 %
Quest Diagnostics Inc	6.96 %

Date modified: 2026-11-06T12:55:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.